Frequent FDA inspections slow down Indian pharma exports, says GV Prasad

GV Prasad, Chairman, CII National Committee on Pharmaceuticals said that everybody should up their game in terms of quality, systems, discipline, integrity of data. All there are important things for the industry. He added that the effect of frequent inspections of Indian pharma manufacturing plants by the FDA and measures to be taken to reduce the impact.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2KxOie0
via IFTTT